Global Chemotherapy-Induced Anemia Clinical Landscape Market Report 2021: Amgen Leads Industry Sponsors with the Highest Overall Number of Clinical Trials for CIA, Followed by Johnson & Johnson
21 juin 2021 04h43 HE
|
Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Chemotherapy-Induced Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...
Global Sickle Cell Anemia Market Report 2021-2031: Key Marketed and Pipeline Drugs, Clinical Trials, Recent Events, Regulatory Events, Success Probability, Disease Prevalence, Licensing & Acquisition
09 juin 2021 08h53 HE
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Sickle Cell...
Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
08 juin 2021 10h30 HE
|
Precipio, Inc.
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
Hematology Analyzers and Reagents Market Growth Sturdy at 7.6% CAGR to Outstrip $13,007.87 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
07 juin 2021 10h46 HE
|
The Insight Partners
Pune, India., June 07, 2021 (GLOBE NEWSWIRE) -- Hematology Analyzers and Reagents Market: Key InsightsAccording to our new research study on “Hematology Analyzers and Reagents Market to 2027 –...
FibroGen to Present at Upcoming Investor Conferences
27 mai 2021 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following...
FibroGen to Report First Quarter 2021 Financial Results
03 mai 2021 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its first quarter 2021 financial results on Monday, May 10 after the market close. FibroGen will also...
FibroGen to Present at Upcoming Investor Conference
28 avr. 2021 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, April 28, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the BofA Securities...
CANADIAN HEALTH INNOVATORS, LUCKY IRON FISH ENTERPRISE, EXPAND THEIR PRESENCE IN MAINLAND CHINA
03 mars 2021 13h47 HE
|
Lucky Iron Fish
Toronto, ON, March 03, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe), a Canadian social enterprise that is committed to tackling iron deficiency, is pleased to announce that, after...
Insights on the Ferritin Testing Global Market to 2027 - by Indication, End-user and Geography
03 févr. 2021 07h23 HE
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Ferritin Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Indication (Anemia, Hemochromatosis, Pregnancy, and Lead Poisoning)...
$397.79 Millions Sickle Cell Anemia Testing and Screening Markets, 2027
29 oct. 2020 07h53 HE
|
Research and Markets
Dublin, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The "Sickle Cell Anemia Testing and Screening - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global...